BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20179939)

  • 1. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma.
    Vandecaveye V; Dirix P; De Keyzer F; de Beeck KO; Vander Poorten V; Roebben I; Nuyts S; Hermans R
    Eur Radiol; 2010 Jul; 20(7):1703-14. PubMed ID: 20179939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma.
    Vandecaveye V; Dirix P; De Keyzer F; Op de Beeck K; Vander Poorten V; Hauben E; Lambrecht M; Nuyts S; Hermans R
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1098-107. PubMed ID: 21514067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results.
    Lambrecht M; Vandecaveye V; De Keyzer F; Roels S; Penninckx F; Van Cutsem E; Filip C; Haustermans K
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):863-70. PubMed ID: 21398048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for uterine cervical cancer.
    Makino H; Kato H; Furui T; Morishige K; Kanematsu M
    J Obstet Gynaecol Res; 2014 Apr; 40(4):1098-104. PubMed ID: 24320754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy.
    Wang L; Liu L; Han C; Liu S; Tian H; Li Z; Ren X; Shi G; Wang Q; Wang G
    Radiother Oncol; 2016 Nov; 121(2):246-251. PubMed ID: 27838148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of diffusion-weighted magnetic resonance imaging at 3.0T for early assessment of tumor response in locally advanced rectal cancer treated with preoperative chemoradiation therapy.
    Delli Pizzi A; Cianci R; Genovesi D; Esposito G; Timpani M; Tavoletta A; Pulsone P; Basilico R; Gabrielli D; Rosa C; Caravatta L; Di Tommaso M; Caulo M; Filippone A
    Abdom Radiol (NY); 2018 Sep; 43(9):2221-2230. PubMed ID: 29332248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redefining the target early during treatment. Can we visualize regional differences within the target volume using sequential diffusion weighted MRI?
    Lambrecht M; Van Herck H; De Keyzer F; Vandecaveye V; Slagmolen P; Suetens P; Hermans R; Nuyts S
    Radiother Oncol; 2014 Feb; 110(2):329-34. PubMed ID: 24231234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
    Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
    Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted magnetic resonance for prediction of response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results of a monoinstitutional prospective study.
    Genovesi D; Filippone A; Ausili Cèfaro G; Trignani M; Vinciguerra A; Augurio A; Di Tommaso M; Borzillo V; Sabatino F; Innocenti P; Liberatore E; Colecchia G; Tartaro A; Cotroneo AR
    Eur J Surg Oncol; 2013 Oct; 39(10):1071-8. PubMed ID: 23953231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology.
    De Cobelli F; Giganti F; Orsenigo E; Cellina M; Esposito A; Agostini G; Albarello L; Mazza E; Ambrosi A; Socci C; Staudacher C; Del Maschio A
    Eur Radiol; 2013 Aug; 23(8):2165-74. PubMed ID: 23588582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of diffusion-weighted imaging without and with including contrast-enhanced magnetic resonance imaging in image analysis of head and neck squamous cell carcinoma.
    Noij DP; Pouwels PJW; Ljumanovic R; Knol DL; Doornaert P; de Bree R; Castelijns JA; de Graaf P
    Eur J Radiol; 2015 Jan; 84(1):108-116. PubMed ID: 25467228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI in head and neck cancer following chemoradiotherapy: what is the optimal delay to demonstrate maximal response?
    Connor SEJ; Burd C; Sivarasan N; Goh V
    Eur Radiol; 2021 Dec; 31(12):9273-9286. PubMed ID: 34009413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma.
    Chen Y; Liu X; Zheng D; Xu L; Hong L; Xu Y; Pan J
    Magn Reson Imaging; 2014 Jul; 32(6):630-7. PubMed ID: 24703576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent Diffusion Coefficient Predicts Pathology Complete Response of Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.
    Chen YG; Chen MQ; Guo YY; Li SC; Wu JX; Xu BH
    PLoS One; 2016; 11(4):e0153944. PubMed ID: 27100991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted imaging for head and neck squamous cell carcinoma: quantifying repeatability to understand early treatment-induced change.
    Hoang JK; Choudhury KR; Chang J; Craciunescu OI; Yoo DS; Brizel DM
    AJR Am J Roentgenol; 2014 Nov; 203(5):1104-8. PubMed ID: 25341151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal diffusion and volumetric kinetics of head and neck cancer magnetic resonance on a 1.5T MR-Linear accelerator hybrid system: A prospective R-IDEAL Stage 2a imaging biomarker characterization/ pre-qualification study.
    El-Habashy DM; Wahid KA; He R; McDonald B; Rigert J; Mulder SJ; Lim TY; Wang X; Yang J; Ding Y; Naser MA; Ng SP; Bahig H; Salzillo TC; Preston KE; Abobakr M; Shehata MA; Elkhouly EA; Alagizy HA; Hegazy AH; Mohammadseid M; Terhaard C; Philippens M; Rosenthal DI; Wang J; Lai SY; Dresner A; Christodouleas JC; Mohamed ASR; Fuller CD
    medRxiv; 2023 May; ():. PubMed ID: 37205359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted MRI for Early Prediction of Treatment Response on Preoperative Chemoradiotherapy for Patients With Locally Advanced Rectal Cancer: A Feasibility Study.
    Jacobs L; Intven M; van Lelyveld N; Philippens M; Burbach M; Seldenrijk K; Los M; Reerink O
    Ann Surg; 2016 Mar; 263(3):522-8. PubMed ID: 26106836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
    Yu Y; Mabray M; Silveira W; Shen PY; Ryan WR; Uzelac A; Yom SS
    Head Neck; 2017 Mar; 39(3):432-438. PubMed ID: 27726241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractional change in apparent diffusion coefficient as an imaging biomarker for predicting treatment response in head and neck cancer treated with chemoradiotherapy.
    Matoba M; Tuji H; Shimode Y; Toyoda I; Kuginuki Y; Miwa K; Tonami H
    AJNR Am J Neuroradiol; 2014 Feb; 35(2):379-85. PubMed ID: 24029391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oesophageal squamous cell carcinoma: histogram-derived ADC parameters are not predictive of tumour response to chemoradiotherapy.
    Kozumi M; Ota H; Yamamoto T; Umezawa R; Matsushita H; Ishikawa Y; Takahashi N; Matsuura T; Takase K; Jingu K
    Eur Radiol; 2018 Oct; 28(10):4296-4305. PubMed ID: 29725833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.